Lung Cancer News

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.

Cancer-related mortality and leading causes of cancer death occurred more frequently in nonmetropolitan areas and among individuals with limited education, according to biennial report from the American Cancer Society.

A 960 mg daily dose of sotorasib conferred a longer OS benefit among certain patients with KRAS G12C-mutant advanced non-small cell lung cancer, results from a randomized phase 2 showed.

The FDA approved repotrectinib for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.

The number of cancer surgeries, chemotherapy treatments and radiation treatments declined dramatically during the first months of the COVID-19 pandemic, study findings published in JAMA Oncology showed.

Healio spoke with Hossein Borghaei, DO, MS, about results from the SAPPHIRE trial presented at this year’s ESMO Congress.

MADRID — Sacituzumab govitecan as a second-line treatment for extensive stage small cell lung cancer showed promising antitumor activity and had manageable safety, according to research presented at ESMO Congress.

Anti-PD-1 therapy reduces de novo production of spike-specific antibodies following vaccination from SARS-CoV-2, according to study findings presented at Society for Immunotherapy of Cancer Annual Meeting.

PHILADELPHIA — Older adults with heart failure have worse physical and mental health than those with several types of cancer, a speaker reported at the American Heart Association Scientific Sessions.

MADRID — A novel antibody-drug conjugate plus osimertinib showed clinical activity and a manageable safety profile in patients with relapsed/refractory, EGFR-mutated non-small cell lung cancer, according to a presentation at ESMO Congress.